The This Is Us actress told Entertainment Tonight the drug gave her stamina for eight Broadway shows a week and quieted her constant thoughts about food.
Recap by typeshit. Full story at Yahoo.
A short Facebook share with no context on who used the peptides, where it happened or what followed.
Benzinga notes a 1.89% after-hours gain for Lilly stock, with Novo Nordisk also tagged. No further detail on what drove the move.
Mikhail Varshavski tells Fox News why protein matters, especially for GLP-1 users. He has a paid partnership with Quest Nutrition.
2:07:50
A live Q&A session covering GLP-1 drugs including Zepbound, Wegovy and Foundayo, with the host taking questions from viewers.
Among Medicare patients with type 2 diabetes, GLP-1 use jumped more than sixteenfold from 2010 to 2022. L'Oréal is also making skincare for rapid weight loss effects.
MedPage Today
MedPage's roundup also notes GLP-1 use among Medicare patients with type 2 diabetes rose more than 16-fold from 2010 to 2022, and L'Oréal building skincare for rapid weight loss.
Loading…